> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# Levitra Not Withdrawn Over Safety/Efficacy: FDA
- URL: https://www.fdaweb.com/levitra-not-withdrawn-over-safety-efficacy-fda/
- Published: 2019-08-12T12:00:00.000Z
- Updated: 2026-09-15T01:43:16.000Z
- Author: David McFarland
- Tags: FDA Policy/General, #legacy-id-D5144742

*Federal Register* notice: FDA has announced an 11/7 public meeting entitled “Promoting Effective Drug Development Programs: Opportunities and Priorities for FDA’s Office of New Drugs.” The meeting will seek specific, actionable policy suggestions that could be implemented in the near-term by CDER’s review staff to promote effective drug development programs without compromising regulatory standards for assessing safety and effectiveness. To view the notice, click [here](https://www.govinfo.gov/content/pkg/FR-2019-08-12/pdf/2019-17209.pdf?ref=fdaweb.com).